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Background: Cardanol was previously reported to be an antiproliferative compound purified from Thai Apis mellifera
propolis. By morphology, it could induce the cell death to many cancer cell lines but not the control (non-transformed
human foreskin fibroblast cell line, Hs27). Here, it was aimed to evaluate the molecular effects of cardanol on breast
cancer derived cell line (BT-474).
Methods: Morphological changes in BT-474 cells induced by cardanol compared to doxorubicin were evaluated by
light microscopy, cytotoxicity by using the 3- (4, 5-dimethyl-thiazol-2-yl) 2, 5-diphenyl-tetrazolium bromide (MTT) assay,
induction of cell cycle arrest and cell death by flow cytometric analysis of propidium iodide and annexin-V stained
cells, and changes in the expression level of genes involved in the control of apoptosis and the cell cycle by
quantitative reverse transcriptase-PCR (qRT-PCR) and western blot analyses.
Results: It revealed that cardanol induced a time- and dose-dependent cytotoxicity along with cell shrinkage and
detachment from substratum. Cardanol caused cell cycle arrest at the G1 subphase (as opposed to at the G2/M subphase
seen with doxorubicin) and cell death by late apoptosis, with both late apoptosis (27.2 ± 1.1 %) and necrosis (25.4 ± 1.4 %)
being found in cardanol treated cells after 72 h, compared to a lower proportion of apoptosis (4.3 ± 0.4 %) and higher
proportion of necrosis (35.8 ± 13.0 %) induced by doxorubicin. Moreover, cardanol changed the transcript expression
levels of genes involved in the control of apoptosis (increased DR5 and Bcl-2 expression and decreased Mcl-1, MADD and
c-FLIPP) and cell division (increased p21 and E2FI and decreased cyclin D1, cyclin E, CDK4 and CDK2 expression), as well as
increasing the level of p21 p-ERK, p-JNK and p-p38 and decreasing cyclin D. This accounts for the failure to progress from
the G1 to the S subphase.
Conclusion: Cardanol is a potential chemotherapeutic agent for breast cancer.
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Propolis, one of honeybee products, has mostly been
used in traditional medicine. As known, the compo-
nents and properties of propolis mainly depend on
the geographic location and bee species. For example,
the propolis derived from bees foraging on poplar
(Populus nigra L.) was found to consist of plant resin
(50 %), wax (30 %), oil (10 %), pollen (5 %) and other
components (5 %) [1].
Propolis has been reported to show many bioactivities,
including antibacterial, antiviral, anti-inflammatory and
antioxidant activities [2–5]. These reports have typically
presented the potential of propolis in the form of either
crude or purified extracts/compounds and assayed in ei-
ther an in vitro or an in vivo model. Also, it was linked
to the regulation of gene expression in many types of
cells like macrophages, spleenocyte cells and human
monocytes [6, 7].
Interestingly, propoelix™, a water-soluble extract of
propolis, has been used successfully in the treatment of
patients with dengue hemorrhagic fever [8]. In addition,
propolis has been reported to be a very rich source of
polyphenolic compounds, flavonoids and fatty acids [9].
For example, baccharin isolated from Brazillian propolis
and its analogs were able to inhibit aldo-keto reductase
1C3 (AKR1C3), which is involved in castration resistant
prostate cancer [10]. The administration of caffeic acid
phenethyl ester (CAPE) at 5 μM/kg in mice by intra-
peritoneal injection showed anti-depressant activity in
mice receiving chronic unpredictable stress for 21
consecutive days. Downregulation of p38MAPK phos-
phorylation by CAPE, which contributed to enhance
glucocorticoid receptor function, has also been re-
ported [11].
The molecular mechanism of those active compounds
has been revealed, or at least in part. For example, CAPE
(25 μM) induces apoptosis in the HeLa cervical cancer
cell line (ME 180) and induces cell cycle arrest at the S
and G2/M subphases. The expression level of the E2F-1
target gene, cyclin A, cyclin E, apoptosis protease acti-
vating of factor-1 (Apaf-1) and myeloid leukemia cell
differentiation protein (Mcl-1) were upregulated but
cyclin B was down-regulated [12].
In addition, chrysin significantly reduced the serum
levels of the pro-inflammatory cytokines IL-1β and IL-6
in high fat diet/streptozotocin -induced type 2 diabetic
rats. Since these pro-inflammatory cytokines, along with
especially TNF-α, have an important function in insulin
resistance and inflammatory responses, chrysin could be
a new target for the treatment of type 2 diabetes [13].
Cardanol, a phenolic compound found in members of
the cashew tree (Anacardiaceae) family, has been associ-
ated with diverse biological effects, such as antiprolifera-
tive, antimicrobial and antioxidant activities [14–17].However, the molecular mode of action of cardanol is
unknown. In this research, the BT-474 cell line, as an
in vitro breast cancer model, was focused because it is
the leading cause of death in Thai women [18]. Here,
the induction of cell cycle arrest as well as program cell
death was reported. The change in the expression level
of genes that control these functions was also investi-
gated. Finally, a molecular mechanism of cardanol action
on the BT-474 cell line is proposed.
Methods
Preparation of propolis
Propolis from Apis mellifera was collected from the
hives at a bee farm in Pua district, Nan province,
Thailand in January, 2012. It was wrapped in aluminum
foil and kept in the dark at −20 °C until used. The
extraction and enrichment to apparent homogeneity
of cardanol from the propolis, along with the one-
dimensional thin layer chromatography (1D-TLC), was
performed as previously reported [14].
Cell culture
The BT-474 cells (ATCC no. HTB 20) was cultured in
complete medium (CM) comprised of Roswell Park
Memorial Institute (RPMI) 1640 medium containing 5 %
(v/v) fetal calf serum. Cells were seeded at 1 × 105 cells/
5 ml CM/ 25-cm2 flask and incubated at 37 °C with 5 %
(v/v) CO2. Cells were re-passaged when they reached
70–80 % confluency.
Cytotoxicity
Cytotoxicity was evaluated indirectly from MTT assay.
Thus, the results are influenced by changes in the
average cell proliferation rate and/or cell viability, and
the reduction in the total number of viable cells is
herein referred to as the cytotoxicity without delinea-
tion of these two components. BT-474 cells (5 103
cells in 198 μl) were seeded in each well of a 96 well
plate, and incubated at 37 °C with 5 % (v/v) CO2 for
24 h. Then 2 μl of cardanol or doxorubicin, dissolved
in dimethylsulfoxide (DMSO) to a concentration of
10000, 1000, 100, 10, 1 and 0.1 μg/ml for cardanol
and 50 μg/ml for doxorubicin, was added to the wells
in triplicate, along with DMSO only (2 μl/well) as the
solvent (no treatment) control. The cells were then
incubated for 72 h before 10 μl of 5 mg/ml of MTT
solution was added to each well and incubated for
another 4 h. After that, the media was removed and
replaced with 150 μl of DMSO and 25 μl of 0.1 M
glycine and gently aspirated to lyse the cells and dis-
solve the formazan crystals. The absorbance was then
measured at 540 nm (A540) by a microplate reader.
Setting the total number of viable cells in the control
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cells was calculated from Eq. (1):
Relative number of viable cells
¼ A540of sample = A540of controlð Þ  100 ð1Þ
The concentration of the test compound that caused a
50 % maximal inhibition of the viable cell number (IC50)
was derived from the graphical plot of the relative num-
ber of viable cells vs. test compound concentration.
Growth curve of BT-474 cells
BT-474 cells treated with solvent only (control) or with
cardanol at the IC50 value (15.6 ± 1.76 μg/ml) were
assayed for the relative number of viable cells using the
MTT assay after 1, 2, 3, 5 and 7 d of culture. The graph of
relative number of viable cells vs. time was drawn, where
the trend line was compared to the control cell line.
Cell morphology
BT-474 cells (2 × 105 cells/ml) were cultured in CM
with the addition of (i) the DMSO solvent only (Con-
trol), (ii) 30 μg/ml of cardanol and (iii) 0.5 μg/ml of
doxorubicin (positive control). The morphology of the
cells was observed after 0, 24, 48, 72 and 96 h incubation
using inverted light microscope (Ziess, Jena) connected
to a digital camera (Canon EOS 7D, Tokyo).
Detection of apoptosis and necrosis
BT-474 cells (3–5 × 106 cells/ml) were cultured in CM
with the addition of (i) the DMSO solvent only (Con-
trol), (ii) 30 μg/ml of cardanol and (iii) 0.5 μg/ml of
doxorubicin (positive control). After the indicated time
in culture (24–72 h) the cells were harvested by centrifu-
gation (3000 × g, 4 °C for 10 min), washed in 1 ml of
cold 1 x phosphate buffer saline (PBS) and harvested as
before. The pellet was resuspended in 50 μl of 1 × bind-
ing buffer pH 7.4 (10 mM Hepes, 140 mM NaCl and
2.5 mM CaCl2) and stained with the addition 1 μl of
annexin V (Alexa Fluor 488 conjugate, Life Technologies,
Carlsbad, CA) and 5 μl of 1 mg/ml propidium iodide (PI)
solution (Sigma Aldrich, St. Louis, MO) in the dark at
room temperature (RT) for 30 min. Cells were then ana-
lyzed by flow cytometry on a FC 500 MPL cytometer
(Beckman Coulter, Brea, CA) recording 2 events (cells).
Detection of cell cycle arrest
BT-474 cells (1–100 × 106 cells/ml) were cultured in
CM with the addition of (i) the DMSO solvent only
(Control), (ii) 30 μg/ml of cardanol and (iii) 0.5 μg/ml of
doxorubicin (positive control) for 24, 48 and 72 h and
then harvested and washed as above. The cell pellet was
resuspended and fixed in 500 μl of cold PBS and 200 μl
of 70 % (v/v) ethanol at −20 °C overnight or on ice for4 h. Cells were then harvested and washed as above and
the pellet resuspended in 250 μl of PBS with 0.1 mg/ml
RNAse and incubated at 37 °C for 30 min. After harvest-
ing, the cells were resuspended in 12.5 μl of 1 mg/ml PI
and incubated at RT in the dark for 30 min before being
analyzed by flow cytometry on a FC 500 MPL cytometer
(Beckman Coulter) recording 2 events per sample. The
obtained linear fluorescence profile was interpreted in
terms of the (1) sub G1 phase (apoptotic cells), (ii) G1
phase (diploid chromosome content), (iii) S phase (DNA
synthesis) and (iv) G2/M subphase (double diploid).
Change in gene expression levels
Transcript expression levels
BT474 cells were cultured in CM with the addition of (i)
the DMSO solvent only (Control), (ii) 30 μg/ml of carda-
nol and (iii) 0.5 μg/ml of doxorubicin (positive control)
for 72 h, and then harvested. Total RNA was then
extracted from them using the RNeasy Plus Mini Kit
(Qiagen, Hilden) as per the suppliers protocol. The ex-
tracted RNA was eluted in 20 μl of RNase-free H2O and
the absorbance at 260 and 280 nm (A260 and A280, re-
spectively) was measured. The concentration of RNA
was calculated from Eq. (2),
Concentration of RNA ðμg=mlÞ ¼ A260ð Þ  dilution factor  40ð Þ:
ð2Þ
The purity of the extracted RNA was estimated from the
A260/A280 ratio. The RNA samples were stored at −20 °C
until use.
The transcript expression levels of the selected genes
were then assayed by single-stage qRT-PCR. Two groups
of genes were selected for screening. The first group were
the death receptor group of the apoptosis regulated genes
b-cell lymphoma-2 (Bcl-2), Mcl-1, mitogen activating
protein-kinase activating death domain (MADD), cellular
FLICE-like inhibitory protein (c-FLIP) and human death
receptor 5 (DR5). The second group were the cell cycle
regulating genes of p21, cyclin D1, cyclin E, cyclin A,
cyclin-dependent kinase 4 (CDK4), CDK6 and CDK2.
The reaction mixture was prepared using the One Step
SYBR PrimeScript RT-PCR Kit II (Takara, Tokyo) as per
the manufacturer’s protocol. Each qRT-PCR reaction
mixture (20 μl final volume) contained total RNA
(10 ng), 10 μl of 2x one step SYBR RT-PCR buffer, 1 μl
of Prime Script 1 step enzyme mix, 0.5 μl of each gene
fragment specific forward and reverse PCR primer
(20 μM stock) and RNase-free d-H2O. The respective
forward and reverse primers are listed in Table 1. The
PCR thermocycling was performed at 95 °C for 15 min,
followed by 40 cycles of 94 °C for 15 s, x °C for 30 s and
72 °C for 30 s, where x is gene specific and is given in
Table 1. The relative expression level of each gene was
Table 1 Forward and reverse primers (5’→ 3’) used in the qRT-PCR
Gene Nucleotide sequence of F primer Nucleotide sequence of R primer Annealing temp. (°C) Reference
ß-actin GACCTGACTGACTACCTCATGA AGCATTTGCGGTGGACGATGGAG 55 Lirdprapamongkol et al. [20]
MADD TCAACCCACTCATCTATGGCAATG GCGGAATTGAAGAACCGTACCA 60 Li et al. [36]
c-FLIP CCAGAGTGTGTATGGTGTGGAT TCTCCCATGAACATCCTCCTGAT 60 Li et al. [36]
Bcl-2 TGGGATGCGGGAGATGTG CGGGATGCGGCTGGAT 60 Li et al. [36]
Mcl-1 AGCAGAGGAGGAGGAGGAC GCCTGCTCCCGAAGGTA 55 Lirdprapamongkol et al. [20]
DR5 TGCTGCTCAAGTGGCGC GGCATCCAGCAGATGGTTG 60 Pillai et al. [37]
P21 CACTCCAAACGCCGGCTGATCTTC TGTAGAGCGGGCCTTTGAGGCCCTC 55 Weglarz et al. [38]
E2F1 GCCACTGACTCTGCCACCA GGACAACAGCGGTTCTTGCT 60 Galanti et al. [39]
Cyclin A GAAGACGAGACGGGTTGCA AGGAGGAACGGTGACATGCT 60 Galanti et al. [39]
Cyclin D1 AATGACCCCGCACGATTTC TCAGGTTCAGGCCTTGCAC 60 Ullmannova et al. [40]
Cyclin E TTCTTGAGCAACACCCTCTTCTGCAGCC TCGCCATATACCGGTCAAAGAAATCTTGTGCC 58 Potemski et al. [41]
CDK2 TTTGGAGTCCCTGTTCGTAC TGCGATAACAAGCTCCGTCC 58 Chiang et al. [42]
CDK4 CTTTGACCTGATTGGGCTGC GGAGAGGTGGGAGGGGAATG 58 Chiang et al. [42]
CDK6 TCTTGCTCCAGTCCAGCTAC AGCAATCCTCCACAGCTCTG 60 Ullmannova et al. [40]
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as an internal control. The crossing point (Cp) was
used to calculated the relative gene expression level
as per Eq. (3),
Relative expression level ¼ 2 Cp actin−Cp targetð Þ: ð3Þ
The Cp value is correlated to the amount of the initial
template and so indicates the expression of the target
mRNA [19].
Protein expression levels
Changes in the expression level of selected proteins were
evaluated by western blot analysis following the protocol
of Lirdprapamongkol et al. [20] with slight modification.
BT-474 cancer cells (2 × 105 cells/ml) were cultured in
CM with the addition of (i) the DMSO solvent only
(Control), (ii) cardanol at the 2x IC50 concentration
(30 μg/ml) and (iii) 0.5 μg/ml of doxorubicin (positive
control) for 24 h. Cells were then harvested and lysed in
150 μl of radioimmunoprecipitation assay buffer, which
contained 1x halt protease phosphatase and phosphatase
inhibitor cocktail with EDTA (Thermo Scientific, Waltham,
MA), on ice. The concentration of protein in the
lysate was measured by the Bradford assay.
Twenty μg of protein was loaded per well of a sodium
dodecyl sulfate polyacrylamide gel (SDS-PAGE) with a 7
and 4 % (w/v) acrylamide separating and stacking gel, re-
spectively. After electrophoresis at 15 mA for 105 min,
the protein was transferred to immobilon-P nylon mem-
brane (Millipore, Billerica, MA) by electroblotting at
100 V for 90 min. The membrane was later blocked with
3 % (w/v) bovine serum albumin (BSA) for 1 h with gen-
tle shaking at RT. After that, the membrane was cut andprobed with the primary antibodies (Cell Signaling
Technology, Danvers, MA) diluted in 3 % (w/v) BSA to
1: 1000 (all except for anti-pERK that was 1: 5000)
overnight at 4 °C in the dark. The membrane was
washed in 1x TBS/T pH 7.6 (20 mM Tris and
137 mM NaCl) and incubated with the diluted horserad-
ish peroxidase-conjugated secondary antibody (Promega,
Fitchburg, WI) in TBS/T containing 5 % (w/v) skim milk
(1: 10000 mouse, 1: 5000 rabbit) with gentle shaking at RT
for 1 h. The bound secondary antibodies were then visual-
ized using western bright ECL reagents (Advansta, Menlo
Park, CA) as per the supplier’s protocol and the image
was captured using an Image Quant LAS 4000 mini
instrument (GE Healthcare Life Sciences, Little Chalfont).
Statistical analysis
Data are expressed as the mean ± one standard deviation
(1 S.D.), derived from triplicate replications in each ex-
periment. The data were analyzed by one way analysis of
variance (ANOVA) followed by Tukey’s test of multiple
comparisons to test for the significance of differences in
the means. Significance was accepted at the p < 0.05




Starting with 90 g of Apis mellifera propolis, 1.54 g of
crude dichloromethane extract (CDE) was obtained and
then further fractionated by successive quick column
and adsorption column chromatography (CC). The ob-
tained cardanol (0.52 mg) was confirmed from its 1D-TLC
derived Rf value [14] and from its mass spectrometry de-
rived spectrum. The IC50 value for the cytotoxicity against
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which was close to the 14.0 ± 1.0 μg/ml previously
reported on this cell line [14].
In order to confirm that the BT-474 cells were healthy
under these culture conditions and were responsive to
cardanol, the growth of BT-474 cells in CM with either
DMSO only (solvent control) or with various concentra-
tions of cardanol (0.001–100 μg/ml) was evaluated, and
is shown in terms of relative to the initial amount as
100 % (Fig. 1). Among the four phases of a usual growth
curve, the total number of viable cells was recorded
from the lag phase to the log (exponential growth) phase
because treated cells at any cardanol concentration started
to die at the end of the log phase. Overall, the inhibition
by cardanol was time- and dose-dependent manner.
Morphological changes in BT-474 cells
The morphology of the control BT-474 cells (Fig. 2a)
showed no major changes over the 96 h culture period
(except for the increased cell density) with most cells be-
ing alive, attached to the substratum and flat in appear-
ance. However, the morphology of the cardanol treated
cells (IC50 concentration of 15.6 ± 1.76 μg/ml) was differ-
ent, with unattached cells being observed after 48 h in-
cubation, whilst the attached cells had started to shrink
and large clumps of cells were observed at 72 h after
treatment with markedly lower cell numbers being
visible after 96 h (Fig. 2b).
Doxorubicin treatment (0.5 μg/ml) induced broadly
similar changes in the BT-474 morphology as those in-
duced by cardanol, except smaller clumps of custard
apple shaped cells and a lower number of viable cells
was observed (Fig. 2c).
Induction of apoptosis and necrosis
The induction of apoptosis and necrosis in BT-474 cells
was determined by the distribution of annexin V and PI
stained cells using flow cytometry. Representative flow
cytometry dot plots are shown in Additional file 1:
Figure S1 in the supplementary information (SI),Fig. 1 Growth curve of the solvent only (Control) and cardanol
treated (0.001–199 μg/ml) BT-474 cell line. Data are shown as the
mean ± 1SD, derived from three independent repeatswhilst the analysis of all three replications is summarized in
Fig. 3. The control cells remained largely viable (98 % at
24 h to 78 % at 72 h) with very few apoptotic cells. In con-
trast, the cardanol (30 μg/ml) treated cells were dead by late
apoptosis at 72 h of incubation (27.2 ± 1.1 %), whereas the
doxorubicin (0.5 μg/ml) treated cells had mostly died by ne-
crosis from 48 h of incubation (29.9 ± 2.9 %) and this pro-
portion was higher (35.8 ± 13.0 %) after 72 h of incubation.
Significant difference between the control and treated cells
in both groups could be noticed after 48 h of exposure.
Cell cycle arrest
The cell cycle position, in terms of the interphase sub-
phases G1, S and G2/M, were identified by the DNA con-
tent as determined by flow cytometric analysis of PI
stained cells. Representative histograms (PI fluorescence vs.
number of cells) are shown in Additional file 2: Figure S2
(SI) and a summary of all the data is shown in Table 2.
For the control cells after 24–72 h culture, around
17–19.3 % of the cells were in the G2/M phase and
66–71.5 % in the G1 phase of the cell cycle. Cardanol
(30 μg/ml) treatment increased the proportion of cells
in the G1 subphase of the cell cycle compared to the
control cells at all three time points, from 66.2 to
72.9 %, 67.2 to 74.6 % and 71.5 to 80.7 % at 24, 48
and 72 h, respectively. Thus, cardanol appeared to induce
the cell cycle arrest of BT-474 cells at the G1 subphase.
Furthermore, 0.5 μg/ml doxorubicin increased the propor-
tion of cells in the G2/M subphase of the cell cycle com-
pared to the control at all three time points, from 19.3 to
20.6 %, 20.1 to 30.0 %, and 17.0 to 41.3 % at 24, 48 and
72 h, respectively. Thus, doxorubicin induced cell cycle
arrest of BT-474 cells at the G2/M subphase.
Changes in gene transcript expression levels
Since 30 μg/ml cardanol induced the late apoptosis of
BT-474 cells after 72 h of incubation, total RNA was
extracted from BT-474 cells at this period and the
transcript level of genes in the apoptosis and cell
cycle regulating groups were evaluated by single stage
qRT-PCR.
Within the apoptosis regulating genes evaluated, car-
danol (30 μg/ml) treatment increased the transcript ex-
pression level of DR5 and Bcl-2 significantly at p < 0.01
but decreased significantly that of Mcl-1 (p < 0.01),
MADD (p < 0.01) and c-FLIP (p < 0.05). Doxorubicin
(0.5 μg/ml) up-regulated the transcript expression level
of Bcl-2 significantly at p < 0.01 but down-regulated sig-
nificantly that of Mcl-1 (p < 0.01), MADD (p < 0.01), c-
FLIP (p < 0.05) and DR5 (p < 0.05) (Fig. 4a). A significant
difference at either p < 0.01 or p < 0.05 levels was com-
pared between the control and treated cells.
For the cell cycle regulation group of genes evaluated,
30 μg/ml cardanol increased the transcript expression
Fig. 2 Morphology of the a control BT-474 cells and those treated with b cardanol at the IC50 concentration (15.6 ± 1.76 μg/ml) and c doxorubicin
(0.5 μg/ml) for (I) 24 h, (II) 48 h, (III) 72 h and (IV) 96 h of incubation. The scale bar represents 50 μM. The arrow indicates custard apple shaped cells.
All images were magnified at 200 x and are representative of at least 3 such fields of view per sample and three independent repeats
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cyclin E, CDK4 and CDK2 significantly at p < 0.01, whilst
0.5 μg/ml doxorubicin up-regulated significantly E2F1,
p21, cyclin A, CDK6 and CDK2 transcript expression
levels (Fig. 4b). A significant difference at p < 0.01 level
was compared between the control and treated cells.
Changes in protein expression levels by western blot
analysis
The protein expression levels of ERK, JNK and p38
MAPK plus their phosphorylated (active) forms (p-ERK,
p-JNK and p-P38), as well as p21 and cyclin D1 in BT-
474 cells was evaluated after a 24 h incubation with or
without 30 μg/ml cardanol or 0.5 μg/ml doxorubicin
(Fig. 5). Cardanol activated ERK, JNK and p38 MAPK,
as seen by the increased expression levels of the phos-
phorylated forms of these three proteins. The increased
phosphorylation of ERK, JNK and p38 MAPK, and so
their active enzyme levels, is likely to have caused the in-
creased the p21 and cyclin D1 expression levels. Overall,
the results strongly suggested that the G1 subphase ar-
rest induced by cardanol was mediated by activation of
the MAPK-p21 pathway.
Discussion
Bees collect nectar, bee pollen and resin from different
plants and so many compounds can found in bee prod-
ucts. For example, α-pinene was reported to be the
major compound in European propolis, and it originated
from many plant species, including coniferous species
like Cupressus sempervirens [21]. Moreover, galangin,
chrysin and pinocembrin were found to be the maincompounds in Serbian propolis, and were similar to the
composition of the resin in poplar trees that are widely
distributed in Europe [22]. The propolis from Hungary,
Bulgaria, France and Northern Italy were all found to
contain resin from poplar trees as well, although the
major compounds found in those propolis types were
the non-terpenic compounds of benzyl alcohol and ben-
zyl benzoate [23]. Benzyl benzoate was not detected in
the volatile oils of poplar buds, although this might re-
flect differences in the volatiles of different poplar sub-
species. Thus, the bud exudates of even of the same
species can demonstrate quantitative variability.
Cardanol inhibited the growth of BT-474 cells in a
time- and dose-dependent manner (Fig. 1), which is
broadly consistent with other reports. For example, the
CEE of propolis harvested from many regions in Korea
inhibited the angiogenesis, as in tube formation of human
umbilical vein endothelial cells (HUVECs), in a dose-
dependent manner (6.25–25 μg/ml) [24]. In addition, the
CEE of propolis from the Uijeongbu and Pyoseon regions
significantly suppressed the proliferation of HUVECs in a
dose dependent manner (3.13–25 μg/ml) [24].
Considering the induction of apoptosis by cardanol
(Fig. 3 and Additional file 1: Figure S1), cardanol killed
BT-474 cells at the late apoptosis (apoptosis and necro-
sis) stage, which was somewhat similar to doxorubicin, a
currently used chemotherapeutic drug, although the later
had a higher proportion of necrotic cells. The induction of
apoptosis like this is commonly found in compounds puri-
fied from natural products, including chemotherapeutic
drugs. In addition to propolis, Tualang honey induced late
apoptosis in human breast adenocarcinoma (MCF-7 and
Fig. 3 The percentage of cell death. Three groups of cells which were stained untreated cells, cardanol treated cells and doxorubicin treated cells
were used. The percentage of livable cells, early apoptosis, late apoptosis, and necrosis was shown. a, b and c represented 24, 48 and 72 h of
incubation. A symbol of “**” represented significant difference between the control and treated cells at p < 0.01
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with an EC50 value of 2.4–2.8 % (v/v) [25]. MDA-
MB-231 cells treated with Tualang honey at 24 h
showed the highest percentage of late apoptosis at
37.8 %, while for MCF-7 and Hela cells it was 55.6
and 56.2 %, respectively [25].
The mechanism of induction of apoptotic cells has
many pathways. In this study, cardanol increased the tran-
script expression level of the Bcl-2 and DR5 apoptosis-
related genes but decreased that of Mcl-1, c-FLIP andTable 2 Summary of the percentage of cells in each interphase sub
Subphase Control Cardanol treat
24 h 48 h 72 h 24 h
Early G1 1.1 ± 0.7 1.3 ± 0.9 1.1 ± 1.0 1.7 ± 1.2
G1 66.2 ± 11.4 67.2 ± 6.3 71.5 ± 8.7 72.9 ± 10.2
S 10.2 ± 1.1 7.7 ± 0.5 7.3 ± 1.7 8.5 ± 4.5
G2/M 19.3 ± 10.2 20.1 ± 6.5 17.0 ± 8.2 14.3 ± 6.7
Data are shown as the mean ± 1 SD, derived from three independent repeatsMADD (Figs. 4 and 5), somewhat similar to doxorubicin
(positive control). The DR5 protein is an apoptosis indu-
cing membrane receptor for TNF-related apoptosis-
inducing ligand, where apoptosis in human renal cancer
cells is induced by up-regulation of DR5 and down-
regulation of c-FLIP [26]. In addition, the combined treat-
ment with rosiglitazone and TNF-α-related apoptosis
inducing ligand (TRAIL) could induce apoptosis in renal
cancer cells via induction of Bcl-2 overexpression [26].
Similarly acrolein can effectively sensitize human renalphase of the cell cycle
ed cells Doxorubicin treated cells
48 h 72 h 24 h 48 h 72 h
2.5 ± 0.6 2.0 ± 1.3 2.0 ± 0.9 3.5 ± 1.1 5.3 ± 3.9
74.6 ± 3.4 80.7 ± 4.1 59.5 ± 11.5 46.9 ± 3.4 31.8 ± 7.9
6.5 ± 7.2 5.8 ± 2.2 13.9 ± 1.8 14.4 ± 7.2 14.0 ± 2.2
13.2 ± 8.2 9.2 ± 5.8 20.6 ± 10.4 30.0 ± 8.2 41.3 ± 1.4
Fig. 5 Western blot analysis of protein expression levels in BT-474
cells after incubation in CM with the addition of DMSO only (Control)
or with 30 μg/ml cardanol or 0.5 μg/ml doxorubicin for 24 h.
Unphosphorylated and phosphorylated forms (p-) of the ERK, p38 and
JNK proteins are shown. The blot shown is representative of those seen
from 3 independent repeats
Fig. 4 The change in transcript expression levels of genes in the
a death receptor group (apoptosis regulating) and b cell cycle
regulating genes (transcription factors important for the cell cycle).
BT-474 cells were cultured for 72 h in CM with the addition of DMSO
only (Control) or 30 μg/ml cardanol or 0.5 μg/ml doxorubicin. Data
are shown as the mean ± 1 SD, derived from three independent
repeats. Significant difference between the control and treated
cells are shown at the (**) p < 0.01 and (*) p < 0.05 levels
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regulating Bcl-2 and up-regulating DR5, mediated via gen-
eration of reactive oxygen species and induction of the
C/EBP homologous protein [27]. Thus, lowering the
TRAIL resistance or increasing the damage of tumor
cells could help in cancer therapy. Moreover, the
knockdown of MADD and c-FLIP reduced the resist-
ance to TRAIL-induced apoptosis in SKOV-3 ovarian
cancer cells to 64.2 ± 3.0 % [27].
The Mcl-1 protein is an anti-apoptotic member in the
Bcl-2 family of apoptosis regulating proteins. Benzyl iso-
thiocyanate, an anti-cancer agent, causes G2/M cell cycle
arrest and apoptosis in human leukemia cell lines via the
down-regulation of Mcl-1 [28].
Cardanol appears to arrest BT-474 cells at the G1 sub-
phase of the cell cycle, somewhat similar to the effect of
propolin H from Taiwanese propolis that arrested the
human lung carcinoma H460 cell line in the G1 sub-
phase. Treatment of H460 cells with 40 μM of propolinH increased the proportion of cells in the G1 subphase
from 57.8 to 75.1 % [29].
Cancer cells display an uncontrolled growth and present
abnormal gene expression profiles. The expression level of
regulating genes, such as cyclin and CDKs, are typically
higher and so induce the cell cycle to move to the next
phase. With respect to the effect of cardanol on BT-474
cells, it affected the expression of many genes important
for the cell cycle, such as decreasing p21, cyclin D1, cyclin
E, CDK2 and CDK4 expression levels and increasing that
for p21 and E2F1. These results are in accord with those
for CAPE at a concentration of 2.5–80 mg/l that increased
the proportion of cells in the G1 subphase in a dose-
dependent manner, and also increased the expression of
beta-catenin and decreased the expression of cyclin D1
and c-myc [30]. In addition, a 24 h exposure to CAPE
Fig. 6 A model of the mechanism of action of cardanol to induce cell cycle arrest at the G1 subphase and cell death in BT-474 cancer cells
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cing cell cycle arrest at the G1 subphase after a 24 h incu-
bation, decreasing the CDK2/cyclin E and CDK4/cyclin D
activity and inhibiting Rb phosphorylation by increasing
p21, p27 and p16 expression [31].
The potential induction of the G1 cell cycle arrest by
cardanol via increasing p21, p-p38 MAPK, p-JNK and p-
ERK protein levels was similar to isothiocyanate sulfo-
raphane, a chemotherapeutic drug. The mechanism of
SFN on human colon carcinoma HT-29 cells was reported
to be mediated via inducing expression of p21CIP1 and
cyclin D1 through activating the MAPK pathways, includ-
ing ERK, JNK and p38 [32].
In this report, doxorubicin was used as positive con-
trol since its action is already well reported [33]. It is an
anthracyline drug extracted from Streptomyces peucetius
var caesivs and has been used for treatment of diverse
cancers, including breast, lung, gastric, ovarian, thyroid,
non-Hodgkin’s and Hodgkin’s lymphoma. The mechan-
ism of action of this drug on cancer inhibition has been
described in two pathways. First, it binds to DNA and
disrupts topoisomerase II-mediated DNA repair. Second,
it produces free radicals and damages the cell mem-
brane, DNA and protein leading to cell death. The data
of this research supported the effect of doxorubicin on
the BT-474 cell line with a cell cycle arrest at the G2/M
subphase, up-regulated transcript expression levels of
Bcl-2, E2F1, p21, cyclin A, CDK6 and CDK2 and down-
regulated expression of Mcl-1, MADD, c-FLIP and cyclin
D1. Thus, doxorubicin is likely to act via inhibiting DNA
synthesis through increased p21 and cyclin D1 activities.
Moreover, doxorubicin decreased the expression level of
the anti-apoptotic genes Mcl-1 and c-FLIP.
In summary, the proposed mechanism of how car-
danol could inhibit the growth of BT-474 cells isshown in Fig. 6. In this model, cardanol increases the
phosphorylation of ERK, JNK and p38 MAPK leading to
p21 activation. Then, the active p21 suppressed CDK4/
cyclin D and cyclin E/CDK2 and so prevented the hyper-
phosphorylation of the retinoblastoma protein. This led to
the obstruction of DNA synthesis and prevented the
movement of cells into and from the S subphase, causing
the G1 subphase arrest.
However, the data mentioned above were from in vitro
only. In the future, primary normal cell culture and ani-
mal models must be performed before going forward to
human testing. As known, in vitro cultured cells can not
represent the whole organism due to lack of precise
control of physicochemical surrounding, physiological
conditions and so on [34].
In addition, it should be aware of an agent with both
anticancer and antioxidant activities. Recently, it has
been contradictorily reported whether such compound
could be applied to the treatment of cancer [35].
Conclusion
Cardanol, purified from Apis mellifera propolis from
Nan province, Thailand, had a cytotoxic activity (IC50
value of 15.6 ± 1.76 μg/ml) against the BT-474 cell
line. The inhibition by cardanol was time- and dose-
dependent manner. Morphologically, cardanol treated
cells revealed a loss of adhesion and cell shrinking
with the formation of large clumps and a reduced number
of viable cells. After 72 h, significant numbers of cells were
dead by late apoptosis. The change in transcript and pro-
tein expression levels of genes involved in apoptosis in-
duction and cell proliferation strongly suggested that the
MAPK regulated p21-mediated G1 phase cell cycle arrest
was a mechanism underlying the growth inhibitory effect
of cardanol on BT-474 cells.
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